Hradec J, Seidel A, Platt K L, Glatt H R, Oesch F, Koblyakov V
Department of Molecular Biology, Research Institute for Tuberculosis and Respiratory Diseases, Prague, Czechoslovakia.
Carcinogenesis. 1990 Nov;11(11):1921-6. doi: 10.1093/carcin/11.11.1921.
A total of 78 polycyclic aromatic compounds (PAH), including pure hydrocarbons, PAH metabolites, aromatic amines and nitroarenes, were tested in the initiator tRNA acceptance assay (tR assay) for carcinogens. Among the pure hydrocarbons, all strong carcinogens were highly active in the tR assay. Some weak carcinogens showed moderate positive responses, others as well as all possible non-carcinogens were inactive. Various PAH metabolites, including phenols, dihydrodiols, arene oxides, dihydrodiol epoxides, quinones and benzylic sulfate esters, were positive as well. Strikingly, however, their effects rarely reached the levels observed with the strong carcinogens among the pure hydrocarbons. Moreover, the correlation with carcinogenicity was less clear, partially due to limitations in the available carcinogenicity data. The activities in the tR assay were also compared with the mutagenicity in Salmonella typhimurium. No appreciable correlation was observed. For example, trans-9,10-dihydroxy-9,10-dihydrobenzo[c]chrysene, in the absence of a mammalian metabolic system, was highly active in the tR assay, but non-mutagenic. Upon addition of rat liver enzymes, the reverse result was obtained. syn-Benzo[c]chrysene-9,10-dihydrodiol-11,12-oxide, on the other hand, was a potent direct mutagen, but required the presence of liver microsomes for a positive response in the tR assay. Thus, the metabolic basis for these two activities is different, and not yet understood for the tR assay. The partial correlations in the tR assay and in the Salmonella mutagenicity assay with carcinogenicity, and the pronounced discrepancies between these in vitro tests, may suggest that they detect different mechanisms involved in carcinogenicity. However, the tR assay was less predictive for the carcinogenicity of PAHs as compared to the previously investigated N-nitroso compounds and mycotoxins.
总共78种多环芳烃化合物(PAH),包括纯烃类、PAH代谢物、芳香胺和硝基芳烃,在致癌物引发剂tRNA接受试验(tR试验)中进行了测试。在纯烃类中,所有强致癌物在tR试验中都具有高活性。一些弱致癌物显示出中等阳性反应,其他的以及所有可能的非致癌物均无活性。各种PAH代谢物,包括酚类、二氢二醇、芳烃氧化物、二氢二醇环氧化物、醌类和苄基硫酸酯,也呈阳性。然而,引人注目的是,它们的效应很少达到纯烃类中强致癌物所观察到的水平。此外,与致癌性的相关性不太明确,部分原因是现有致癌性数据存在局限性。tR试验中的活性也与鼠伤寒沙门氏菌中的诱变性进行了比较。未观察到明显的相关性。例如,反式-9,10-二羟基-9,10-二氢苯并[c]芘,在没有哺乳动物代谢系统的情况下,在tR试验中具有高活性,但无致突变性。加入大鼠肝脏酶后,得到了相反的结果。另一方面,顺式苯并[c]芘-9,10-二氢二醇-11,12-氧化物是一种有效的直接诱变剂,但在tR试验中需要有肝微粒体才会出现阳性反应。因此,这两种活性的代谢基础不同,tR试验对此尚未了解。tR试验和沙门氏菌诱变性试验与致癌性的部分相关性,以及这些体外试验之间明显的差异,可能表明它们检测到了致癌性中不同的机制。然而,与先前研究的N-亚硝基化合物和霉菌毒素相比,tR试验对PAHs致癌性的预测性较差。